Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans
- 30 April 1991
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 87 (2-3), 147-157
- https://doi.org/10.1016/0021-9150(91)90017-w
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Lipid Lowering Drugs in Atherosclerosis—the HMG-CoA Reductase InhibitorsClinical and Experimental Hypertension. Part A: Theory and Practice, 1989
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert PanelArchives of Internal Medicine, 1988
- Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987
- Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.JCI Insight, 1986
- Consensus conference. Lowering blood cholesterol to prevent heart diseasePublished by American Medical Association (AMA) ,1985
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984
- An improved detection system applied to the study of serum lipoproteins after single-step density gradient ultracentrifugationAnalytical Biochemistry, 1981
- Bile sequestrant therapy alters the compositions of low-density and high-density lipoproteinsMetabolism, 1979
- The Ultracentrifugal Characterization and Isolation of Human Blood Lipids and Lipoproteins, with Applications to the Study of Atherosclerosis.The Journal of Physical Chemistry, 1951